Dodla Dairy disputes FSSAI referral lab finding on Batlagundu milk sample
As filed · Dodla Dairy Limited has informed the Exchange about Rumour Verification - Regulation 30(11)
What happened
FactDodla Dairy said an FSSAI referral laboratory classified a Full Cream Milk sample as unsafe and substandard, citing qualitative presence of detergent/caustic soda, while the primary laboratory had found the sample substandard only on milk fat and recorded detergent and neutralizers as absent. The company said it challenged the referral report on 24 April 2026, has not received a formal prosecution order or sanction, and currently sees no financial or operational impact.
Why it matters
CapitSignal interpretationLitigation creates a contingent liability that is not in reported profit until it crystallises.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
WithdrawnAs of FY24, Dodla operates 604 retail parlours, strategically located to enhance market penetration and provide consumers with easy access to their wide range of dairy products.
With extended summers, our VAP portfolio, including curd, buttermilk, lassi, and ice cream, delivered record sales, reaching about a third of our total sales.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Amount claimed against the company
- Whether a provision has been made
- Next hearing or order date
- Maintain our normal steady, I think the 8% to 10% in India as volume growth and the price hikes will add to th (management committed by FY27)
- we look at another around 2%, 2.5% correction in the prices in the ongoing quarter that we look at. (management committed by Q1 FY27)
Evidence
- Dodla Dairy Limited has informed the Exchange about Rumour Verification - Regulation 30(11)(opens the original filing in a new tab)
- Earlier statement · FY24
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- The matter could create regulatory and reputational risk because the referral laboratory reported an unsafe finding. However, the company says the laboratory results diverged, it has submitted a representation, and no formal prosecution order or sanction has been received.
- Matched on:
- body text (weaker evidence than a subject match)
- Confidence in the event type:
- 50%